E
Waverley Pharma Inc.
WAVE.V
TSX
E
Sell
10/13/2023Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 10/13/2023 due to a decline in the valuation index and volatility index.
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 10/13/2023 due to a decline in the valuation index and volatility index.
D
Sell
9/28/2023Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 9/28/2023 due to an increase in the valuation index, volatility index and total return index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 9/28/2023 due to an increase in the valuation index, volatility index and total return index.
E
Sell
8/21/2023Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 8/21/2023 due to a decline in the valuation index, solvency index and volatility index. The quick ratio declined from 0.15 to 0.05, and debt to equity increased from 1.05 to 1.74.
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 8/21/2023 due to a decline in the valuation index, solvency index and volatility index. The quick ratio declined from 0.15 to 0.05, and debt to equity increased from 1.05 to 1.74.
D
Sell
8/4/2023Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 8/4/2023 due to an increase in the volatility index, total return index and valuation index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 8/4/2023 due to an increase in the volatility index, total return index and valuation index.
E
Sell
7/14/2023Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 7/14/2023 due to a decline in the total return index and volatility index.
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 7/14/2023 due to a decline in the total return index and volatility index.
D
Sell
6/29/2023Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 6/29/2023 due to an increase in the valuation index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 6/29/2023 due to an increase in the valuation index.
E
Sell
6/12/2023Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 6/12/2023 due to a decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.0028 to -$0.0074, debt to equity increased from 0.64 to 1.05, and total revenue declined 33.61% from $132.1 to $87.7.
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 6/12/2023 due to a decline in the growth index, solvency index and valuation index. Earnings per share declined from -$0.0028 to -$0.0074, debt to equity increased from 0.64 to 1.05, and total revenue declined 33.61% from $132.1 to $87.7.
D
Sell
5/31/2023Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 5/31/2023 due to an increase in the volatility index and total return index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 5/31/2023 due to an increase in the volatility index and total return index.
E
Sell
5/12/2023Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 5/12/2023 due to a decline in the solvency index, volatility index and total return index. Debt to equity increased from 0.37 to 0.64, and the quick ratio declined from 0.37 to 0.21.
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 5/12/2023 due to a decline in the solvency index, volatility index and total return index. Debt to equity increased from 0.37 to 0.64, and the quick ratio declined from 0.37 to 0.21.
D
Sell
5/2/2023Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 5/2/2023 due to an increase in the volatility index and valuation index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 5/2/2023 due to an increase in the volatility index and valuation index.
E
Sell
4/17/2023Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 4/17/2023 due to a decline in the volatility index.
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 4/17/2023 due to a decline in the volatility index.
D
Sell
3/30/2023Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 3/30/2023 due to an increase in the total return index and volatility index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 3/30/2023 due to an increase in the total return index and volatility index.
E
Sell
3/14/2023Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D on 3/14/2023 due to a decline in the volatility index.
D
Sell
3/6/2023Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 3/6/2023 due to an increase in the volatility index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 3/6/2023 due to an increase in the volatility index.
D
Sell
2/16/2023Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 2/16/2023 due to a decline in the volatility index.
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 2/16/2023 due to a decline in the volatility index.
D
Sell
2/1/2023Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 2/1/2023 due to an increase in the volatility index and total return index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 2/1/2023 due to an increase in the volatility index and total return index.
D
Sell
1/4/2023Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 1/4/2023 due to a decline in the total return index and volatility index.
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 1/4/2023 due to a decline in the total return index and volatility index.
D
Sell
12/13/2022Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 12/13/2022 due to an increase in the volatility index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 12/13/2022 due to an increase in the volatility index.
D
Sell
11/28/2022Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 11/28/2022 due to a noticeable decline in the growth index and solvency index. Operating cash flow declined 1,725.25% from $9.9 to -$160.9, debt to equity increased from 0.05 to 0.37, and earnings per share declined from -$0.0003 to -$0.0017.
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 11/28/2022 due to a noticeable decline in the growth index and solvency index. Operating cash flow declined 1,725.25% from $9.9 to -$160.9, debt to equity increased from 0.05 to 0.37, and earnings per share declined from -$0.0003 to -$0.0017.
D
Sell
5/16/2022Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/4/2022Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D from E+ on 05/04/2022.
Waverley Pharma Inc. (WAVE.V) was upgraded to D from E+ on 05/04/2022.
E
Sell
5/1/2022Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D on 5/1/2022 due to a decline in the solvency index, volatility index and valuation index. Debt to equity increased from 0.03 to 0.15, and the quick ratio declined from 0.54 to 0.45.
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D on 5/1/2022 due to a decline in the solvency index, volatility index and valuation index. Debt to equity increased from 0.03 to 0.15, and the quick ratio declined from 0.54 to 0.45.
D
Sell
4/21/2022Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D from E+ on 04/21/2022.
Waverley Pharma Inc. (WAVE.V) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D on 4/20/2022 due to a major decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0022 to -$0.003, total revenue declined 31.33% from $442.4 to $303.8, and EBIT declined 24.8% from -$127.8 to -$159.5.
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D on 4/20/2022 due to a major decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0022 to -$0.003, total revenue declined 31.33% from $442.4 to $303.8, and EBIT declined 24.8% from -$127.8 to -$159.5.
D
Sell
11/23/2021Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 11/8/2021 due to a decline in the solvency index. The quick ratio declined from 0.74 to 0.53.
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 11/8/2021 due to a decline in the solvency index. The quick ratio declined from 0.74 to 0.53.
D
Sell
8/5/2020Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 8/5/2020 due to an increase in the volatility index and total return index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 8/5/2020 due to an increase in the volatility index and total return index.
D
Sell
7/21/2020Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 7/21/2020 due to a decline in the volatility index.
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 7/21/2020 due to a decline in the volatility index.
D
Sell
7/2/2020Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 7/2/2020 due to an increase in the volatility index and total return index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 7/2/2020 due to an increase in the volatility index and total return index.
D
Sell
6/17/2020Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 6/17/2020 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 1.55 to 1.34.
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 6/17/2020 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 1.55 to 1.34.
D
Sell
5/1/2020Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 5/1/2020 due to an increase in the growth index and valuation index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 5/1/2020 due to an increase in the growth index and valuation index.
D
Sell
3/23/2020Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 3/23/2020 due to a decline in the total return index.
Waverley Pharma Inc. (WAVE.V) was downgraded to D- from D on 3/23/2020 due to a decline in the total return index.
D
Sell
2/12/2020Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 2/12/2020 due to an increase in the valuation index, growth index and volatility index.
Waverley Pharma Inc. (WAVE.V) was upgraded to D from D- on 2/12/2020 due to an increase in the valuation index, growth index and volatility index.
D
Sell
11/29/2018Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 11/29/2018 due to a large increase in the growth index and total return index. Earnings per share increased from -$0.0088 to -$0.0024, operating cash flow increased 70.73% from -$445.9 to -$130.5, and EBIT increased 64.07% from -$485.1 to -$174.3.
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E+ on 11/29/2018 due to a large increase in the growth index and total return index. Earnings per share increased from -$0.0088 to -$0.0024, operating cash flow increased 70.73% from -$445.9 to -$130.5, and EBIT increased 64.07% from -$485.1 to -$174.3.
E
Sell
8/30/2018Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 8/30/2018 due to a noticeable decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0051 to -$0.0088, EBIT declined 68.09% from -$288.6 to -$485.1, and operating cash flow declined 29.28% from -$344.9 to -$445.9.
Waverley Pharma Inc. (WAVE.V) was downgraded to E+ from D- on 8/30/2018 due to a noticeable decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.0051 to -$0.0088, EBIT declined 68.09% from -$288.6 to -$485.1, and operating cash flow declined 29.28% from -$344.9 to -$445.9.
D
Sell
7/2/2018Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E on 7/2/2018 due to a substantial increase in the solvency index and growth index. Earnings per share increased from -$0.034 to -$0.0051, and the quick ratio increased from 7.4 to 9.78.
Waverley Pharma Inc. (WAVE.V) was upgraded to D- from E on 7/2/2018 due to a substantial increase in the solvency index and growth index. Earnings per share increased from -$0.034 to -$0.0051, and the quick ratio increased from 7.4 to 9.78.
E
Sell
4/11/2018Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to E from E- on 04/11/2018.
Waverley Pharma Inc. (WAVE.V) was upgraded to E from E- on 04/11/2018.
E
Sell
3/27/2018Downgrade
Waverley Pharma Inc. (WAVE.V) was downgraded to E- from E on 3/27/2018 due to a decline in the volatility index and total return index.
Waverley Pharma Inc. (WAVE.V) was downgraded to E- from E on 3/27/2018 due to a decline in the volatility index and total return index.
E
Sell
3/7/2018Upgraded
Waverley Pharma Inc. (WAVE.V) was upgraded to E from E- on 3/7/2018 due to an increase in the volatility index and total return index.
Waverley Pharma Inc. (WAVE.V) was upgraded to E from E- on 3/7/2018 due to an increase in the volatility index and total return index.
E
Sell
1/22/2018None
Waverley Pharma Inc. (WAVE.V) was downgraded to E- from U on 01/22/2018.
Waverley Pharma Inc. (WAVE.V) was downgraded to E- from U on 01/22/2018.
